Analysts: Isis Pharmaceuticals Inc (ISIS.OQ)

ISIS.OQ on NASDAQ Stock Exchange Global Select Market

28.87USD
11:19am EDT
Price Change (% chg)

$-0.42 (-1.43%)
Prev Close
$29.29
Open
$29.08
Day's High
$29.18
Day's Low
$28.73
Volume
69,615
Avg. Vol
507,698
52-wk High
$34.30
52-wk Low
$7.55

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold -0.28 December 2 Aug 2013

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 2 2
(2) OUTPERFORM 3 3 2 2
(3) HOLD 3 4 4 4
(4) UNDERPERFORM 1 0 0 0
(5) SELL 1 1 1 1
No Opinion 0 0 0 0
Mean Rating 2.78 2.67 2.56 2.56

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-13 9 18.38 29.70 10.38 24.14
Quarter Ending Dec-13 9 31.25 95.40 15.50 25.59
Year Ending Dec-13 9 119.72 170.10 91.40 112.20
Year Ending Dec-14 9 115.96 177.75 70.90 151.48
Earnings (per share)
Quarter Ending Sep-13 9 -0.28 -0.19 -0.37 -0.32
Quarter Ending Dec-13 9 -0.19 0.32 -0.34 -0.33
Year Ending Dec-13 9 -0.70 -0.28 -0.99 -0.93
Year Ending Dec-14 9 -0.81 -0.06 -1.33 -0.50

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-13 45.24 43.36 1.88 4.16
Quarter Ending Dec-12 15.78 19.87 4.09 25.93
Quarter Ending Sep-12 23.11 11.60 11.51 49.81
Quarter Ending Jun-12 40.06 47.34 7.28 18.17
Quarter Ending Mar-12 22.72 23.24 0.52 2.27
Earnings (per share)
Quarter Ending Mar-13 -0.02 -0.03 0.01 -22.95
Quarter Ending Dec-12 -0.23 -0.23 0.00 -1.95
Quarter Ending Sep-12 -0.26 -0.33 0.07 -25.33
Quarter Ending Jun-12 -0.09 -0.01 0.08 -88.24
Quarter Ending Mar-12 -0.26 -0.24 0.02 -7.26

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-13 18.38 18.38 18.38 16.97 24.14
Quarter Ending Dec-13 31.25 31.25 31.25 31.25 25.59
Year Ending Dec-13 119.72 119.72 118.61 116.88 112.20
Year Ending Dec-14 115.96 115.96 115.96 112.24 151.48
Earnings (per share)
Quarter Ending Sep-13 -0.28 -0.28 -0.28 -0.29 -0.32
Quarter Ending Dec-13 -0.19 -0.19 -0.19 -0.19 -0.33
Quarter Ending Dec-13 -0.70 -0.70 -0.71 -0.73 -0.93
Quarter Ending Dec-14 -0.81 -0.81 -0.81 -0.81 -0.50

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-13 0 0 0 1
Quarter Ending Dec-13 0 0 0 1
Year Ending Dec-13 0 0 1 0
Year Ending Dec-14 0 0 1 0
Earnings
Quarter Ending Sep-13 0 0 0 0
Quarter Ending Dec-13 0 0 0 0
Year Ending Dec-13 0 0 1 0
Year Ending Dec-14 0 0 1 0

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: S&P Capital IQ Quantitative Report
$58.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks